Avanos Medical (AVNS) Free Cash Flow (2013 - 2026)

Avanos Medical has disclosed Free Cash Flow across 14 years of filings, most recently posting -$16.6 million for Q1 2026.

• Free Cash Flow for Q1 2026 came in at -$16.6 million, down 187.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $37.5 million (down 70.29% YoY), and the FY2025 annual result was $73.1 million, down 23.13% from the prior year.
• Free Cash Flow came in at -$16.6 million for Q1 2026 at Avanos Medical, down from $51.3 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $65.3 million in Q4 2024 to a low of -$16.6 million in Q1 2026.
• The 5-year median for Free Cash Flow is $19.0 million (2025), against an average of $14.9 million.
• Across the five-year window, Free Cash Flow slumped 237.5% in 2023 and jumped 860.29% in 2024, its largest moves.
• Avanos Medical's Free Cash Flow stood at $44.2 million in 2022, then slumped by 84.62% to $6.8 million in 2023, then surged by 860.29% to $65.3 million in 2024, then declined by 21.44% to $51.3 million in 2025, then sank by 132.36% to -$16.6 million in 2026.
• The last three Free Cash Flow figures came in at -$16.6 million (Q1 2026), $51.3 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.